TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 150 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q4 2016. The put-call ratio across all filers is 2.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $5,724,000 | -39.3% | 58,509 | -28.5% | 0.16% | +18.8% |
Q2 2018 | $9,428,000 | +133.5% | 81,784 | +100.0% | 0.14% | +12.2% |
Q1 2018 | $4,038,000 | -11.9% | 40,892 | +0.5% | 0.12% | -21.2% |
Q3 2017 | $4,583,000 | +0.5% | 40,673 | 0.0% | 0.16% | -1.3% |
Q2 2017 | $4,558,000 | -2.0% | 40,673 | +2.0% | 0.16% | -7.1% |
Q1 2017 | $4,651,000 | +24.0% | 39,885 | +11.9% | 0.17% | +21.4% |
Q4 2016 | $3,751,000 | +13.2% | 35,633 | +18.8% | 0.14% | +12.0% |
Q3 2016 | $3,315,000 | -24.1% | 30,000 | 0.0% | 0.12% | -25.1% |
Q2 2016 | $4,368,000 | +1.6% | 30,000 | 0.0% | 0.17% | +2.5% |
Q1 2016 | $4,298,000 | -7.3% | 30,000 | 0.0% | 0.16% | -4.1% |
Q4 2015 | $4,637,000 | +8.2% | 30,000 | 0.0% | 0.17% | +1.2% |
Q3 2015 | $4,287,000 | -50.3% | 30,000 | -50.0% | 0.17% | +8.4% |
Q2 2015 | $8,622,000 | +103.8% | 60,000 | +100.0% | 0.16% | +5.4% |
Q1 2015 | $4,231,000 | – | 30,000 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ISZO CAPITAL LP | 1,104,068 | $104,886,000 | 77.66% |
Greywolf Capital Management LP | 472,135 | $46,694,000 | 10.17% |
Consonance Capital Management LP | 263,732 | $26,083,000 | 4.28% |
Moab Capital Partners | 83,132 | $8,222,000 | 3.77% |
Raging Capital Management, LLC | 190,151 | $18,806,000 | 3.45% |
Valentine Capital Asset Management, Inc. | 145,053 | $14,346,000 | 3.07% |
Assured Investment Management LLC | 1,353,342 | $133,846,000 | 1.21% |
Ativo Capital Management LLC | 22,828 | $2,258,000 | 0.99% |
Perceptive Advisors | 56,602 | $5,598,000 | 0.67% |
Jaffetilchin Investment Partners, LLC | 7,721 | $764,000 | 0.38% |